new Interim Recommendations on Vaccination against Ebola Virus Disease from SAGE

SAGE (Стратегическая консультативная группа экспертов)
13 май 2019

Over the last four weeks, the Ebola outbreak in the Eastern Provinces of the Democratic Republic of Congo (DRC) has deteriorated with a large increase in the number of cases1. A major factor in this rise is an increase in critical security incidents that have dramatically affected the ability to identify, follow up and vaccinate contacts successfully. This context challenges the implementation of ring vaccination based on the identification of contacts and contacts of contacts, as recommended by SAGE in April 2017 and confirmed by SAGE during its April 2019 meeting. Further, a potential vaccine shortage may manifest in case the outbreak expands further and/or is prolonged.

ebola.png

SAGE deliberated on the following recommendations on implementation of novel strategies and adjusted dose regimes:

  1. Implementation of innovative operational strategies
  2. Revised vaccination strategy to adjust the target population for ring vaccination to include a second and third barrier of immunized individuals around each incident case.
  3. Alternative dosing for the rVSV-ZEBOV-GP vaccine
  4. Proposal to further adjust the protocol to incorporate alternative individual informed consent forms
  5. Implementation of a mass communication campaign
Документы для загрузки

Другие новости по теме & События

  • Бельгия
    SAGE (Стратегическая консультативная группа экспертов)

    New advisory report for the vaccination against Tick-Borne Encephalitis

    21.03.2019

    The Superior Health Council (SHC) received 2 requests for an advisory report by letter, on May 12 2017 from the Risk Management Group (FPS Health, Food Chain Safety and Environment) and on November 14 2018 from the federal Minister of Health. Both requests are treated in this advisory report.
     

    Читать далее
  • SAGE (Стратегическая консультативная группа экспертов)

    The latest WHO position paper on BCG vaccines

    28.02.2018

    This position paper replaces the 2004 WHO position paper on Bacille Calmette-Guérin (BCG) vaccine and the 2007 WHO revised BCG vaccination guidelines for infants at risk for human immunodeficiency virus (HIV) infection. It incorporates recent developments in the field of tuberculosis, provides revised guidance on the immunization of children infected with HIV, and re-emphasizes the importance of the BCG birth dose.

    Читать далее
  • 13 -24
    май
    Франция

    Advanced Course of Vaccinology

    ADVAC 20th
    Fondation Mérieux & Université de Genève
    Les pensieres, Veryier-du-lac